Rapid COJEC vs standard induction therapies
Overall survival · patients with high‐risk neuroblastoma
Rapid COJEC showed no clear difference in overall survival compared with standard induction therapies (low certainty).
1 finding from 1 review
- Rapid COJEC versus standard induction therapies for high‐risk neuroblastoma 2015 · Cochrane Headline outcomes onlyHR 0.83 [0.63, 1.1]1 study · 262 participantsLow